Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market 2021-2031 by Product Type (API, FDF), Service Type (Preclinical, Clinical, Commercial), Customer Type (Pharmaceutical Firms, Biotechnology Firms), Therapeutic Area (Infectious Diseases, Oncology, Ophthalmology, Cardiovascular Disorders, Central Nervous System, Respiratory Disorders, Metabolic Diseases), and Region: Trend Forecast and Growth Opportunity

December 2022 | 166 pages | ID: G953B8C746A9EN
GMD Research

Abstracts

Global small molecule contract development and manufacturing organization (CDMO) market will reach $117,920.3 million by 2031, growing by 6.4% annually over 2021-2031, driven by the increasing demand for small molecule medicines and therapies, a rising demand for cost control in drug development, the increasing incidence of disease, and rising healthcare expenditures.

Highlighted with 83 tables and 84 figures, this 166-page report “Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market 2021-2031 by Product Type (API, FDF), Service Type (Preclinical, Clinical, Commercial), Customer Type (Pharmaceutical Firms, Biotechnology Firms), Therapeutic Area (Infectious Diseases, Oncology, Ophthalmology, Cardiovascular Disorders, Central Nervous System, Respiratory Disorders, Metabolic Diseases), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global small molecule contract development and manufacturing organization (CDMO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global small molecule contract development and manufacturing organization (CDMO) market in every aspect of the classification from perspectives of Product Type, Service Type, Customer Type, Therapeutic Area, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Active Pharmaceutical Ingredients (API)
• Branded Drugs
• Generic Drugs
• Finished Dosage Formulations (FDF)
• Oral Solid Drugs
• Injectable Drugs
• Semi-solid or Liquid Drugs
• Other FDFs

Based on Service Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Preclinical Use
• Clinical Use
• Phase I
• Phase II
• Phase III
• Phase IV
• Commercial Use

By Customer Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Pharmaceutical Firms
• Biotechnology Firms

By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Metabolic Diseases
• Other Therapeutic Areas

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE?Saudi Arabia? South Africa and Rest of MEA)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product Type, Service Type and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Boehringer Ingelheim

Cambrex Corporation

Catalent

Cipla

Covance Inc.

Lonza Group Ltd.

Medley Pharmaceuticals

NatcoPharma

Patheon (Thermo Fisher Scientific, Inc.)

Piramal Pharma Solutions

RedHillBiopharma

Siegfried Holding AG

STA Pharmaceutical

Sun Pharmaceutical

Teva

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT TYPE

3.1 Market Overview by Product Type
3.2 Active Pharmaceutical Ingredients (API)
  3.2.1 Branded Drugs
  3.2.2 Generic Drugs
3.3 Finished Dosage Formulations (FDF)
  3.3.1 Oral Solid Drugs
  3.3.2 Injectable Drugs
  3.3.3 Semi-solid or Liquid Drugs
  3.3.4 Other FDFs

4 SEGMENTATION OF GLOBAL MARKET BY SERVICE TYPE

4.1 Market Overview by Service Type
4.2 Preclinical Use
4.3 Clinical Use
  4.3.1 Phase I
  4.3.2 Phase II
  4.3.3 Phase III
  4.3.4 Phase IV
4.4 Commercial Use

5 SEGMENTATION OF GLOBAL MARKET BY CUSTOMER TYPE

5.1 Market Overview by Customer Type
5.2 Pharmaceutical Firms
5.3 Biotechnology Firms

6 SEGMENTATION OF GLOBAL MARKET BY THERAPEUTIC AREA

6.1 Market Overview by Therapeutic Area
6.2 Infectious Diseases
6.3 Oncology
6.4 Ophthalmology
6.5 Cardiovascular Disorders
6.6 Central Nervous System
6.7 Respiratory Disorders
6.8 Metabolic Diseases
6.9 Other Therapeutic Areas

7 SEGMENTATION OF GLOBAL MARKET BY REGION

7.1 Geographic Market Overview 2021-2031
7.2 North America Market 2021-2031 by Country
  7.2.1 Overview of North America Market
  7.2.2 U.S.
  7.2.3 Canada
  7.2.4 Mexico
7.3 European Market 2021-2031 by Country
  7.3.1 Overview of European Market
  7.3.2 Germany
  7.3.3 U.K.
  7.3.4 France
  7.3.5 Spain
  7.3.6 Italy
  7.3.7 Netherlands
  7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2021-2031 by Country
  7.4.1 Overview of Asia-Pacific Market
  7.4.2 Japan
  7.4.3 China
  7.4.4 Australia
  7.4.5 India
  7.4.6 South Korea
  7.4.7 Rest of APAC Region
7.5 South America Market 2021-2031 by Country
  7.5.1 Argentina
  7.5.2 Brazil
  7.5.3 Chile
  7.5.4 Rest of South America Market
7.6 MEA Market 2021-2031 by Country
  7.6.1 UAE
  7.6.2 Saudi Arabia
  7.6.3 South Africa
  7.6.4 Other National Markets

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
Boehringer Ingelheim
Cambrex Corporation
Catalent
Cipla
Covance Inc.
Lonza Group Ltd.
Medley Pharmaceuticals
NatcoPharma
Patheon (Thermo Fisher Scientific, Inc.)
Piramal Pharma Solutions
RedHillBiopharma
Siegfried Holding AG
STA Pharmaceutical
Sun Pharmaceutical
Teva
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Global Small Molecule CDMO Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Worldwide Total Number of Registered Clinical Trials
Table 4. Main Product Trends and Market Opportunities in Global Small Molecule CDMO Market
Table 5. Global Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 6. Global Small Molecule CDMO Market: API by Type, 2021-2031, $ mn
Table 7. Global Small Molecule CDMO Market: FDF by Type, 2021-2031, $ mn
Table 8. Global Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 9. Global Small Molecule CDMO Market: Clinical Use by Type, 2021-2031, $ mn
Table 10. Global Small Molecule CDMO Market by Customer Type, 2021-2031, $ mn
Table 11. Global Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 12. Global Small Molecule CDMO Market by Region, 2021-2031, $ mn
Table 13. Leading National Small Molecule CDMO Market, 2021 and 2031, $ mn
Table 14. North America Small Molecule CDMO Market by Country, 2021-2031, $ mn
Table 15. U.S. Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 16. U.S. Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 17. U.S. Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 18. Canada Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 19. Canada Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 20. Canada Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 21. Mexico Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 22. Mexico Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 23. Mexico Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 24. Europe Small Molecule CDMO Market by Country, 2021-2031, $ mn
Table 25. Germany Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 26. Germany Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 27. Germany Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 28. U.K. Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 29. U.K. Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 30. U.K. Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 31. France Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 32. France Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 33. France Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 34. Spain Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 35. Spain Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 36. Spain Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 37. Italy Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 38. Italy Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 39. Italy Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 40. Netherlands Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 41. Netherlands Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 42. Netherlands Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 43. Small Molecule CDMO Market in Rest of Europe by Country, 2021-2031, $ mn
Table 44. APAC Small Molecule CDMO Market by Country, 2021-2031, $ mn
Table 45. Japan Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 46. Japan Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 47. Japan Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 48. China Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 49. China Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 50. China Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 51. Australia Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 52. Australia Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 53. Australia Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 54. India Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 55. India Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 56. India Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 57. South Korea Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 58. South Korea Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 59. South Korea Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 60. Small Molecule CDMO Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 61. South America Small Molecule CDMO Market by Country, 2021-2031, $ mn
Table 62. Argentina Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 63. Argentina Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 64. Argentina Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 65. Brazil Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 66. Brazil Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 67. Brazil Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 68. Chile Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 69. Chile Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 70. Chile Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 71. MEA Small Molecule CDMO Market by Country, 2021-2031, $ mn
Table 72. UAE Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 73. UAE Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 74. UAE Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 75. Saudi Arabia Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 76. Saudi Arabia Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 77. Saudi Arabia Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 78. South Africa Small Molecule CDMO Market by Product Type, 2021-2031, $ mn
Table 79. South Africa Small Molecule CDMO Market by Service Type, 2021-2031, $ mn
Table 80. South Africa Small Molecule CDMO Market by Therapeutic Area, 2021-2031, $ mn
Table 81. Boehringer Ingelheim: Company Snapshot
Table 82. Boehringer Ingelheim: Business Segmentation
Table 83. Boehringer Ingelheim: Product Portfolio

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Global Small Molecule CDMO Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Small Molecule CDMO Market
Figure 7. Primary Restraints and Impact Factors of Global Small Molecule CDMO Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of Global Small Molecule CDMO Market
Figure 10. Breakdown of Global Small Molecule CDMO Market by Product Type, 2021-2031, % of Revenue
Figure 11. Global Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%)
Figure 12. Global Small Molecule CDMO Market by Product Type: Active Pharmaceutical Ingredients (API), 2021-2031, $ mn
Figure 13. Global Small Molecule CDMO Market by API: Branded Drugs, 2021-2031, $ mn
Figure 14. Global Small Molecule CDMO Market by API: Generic Drugs, 2021-2031, $ mn
Figure 15. Global Small Molecule CDMO Market by Product Type: Finished Dosage Formulations (FDF), 2021-2031, $ mn
Figure 16. Global Small Molecule CDMO Market by FDF: Oral Solid Drugs, 2021-2031, $ mn
Figure 17. Global Small Molecule CDMO Market by FDF: Injectable Drugs, 2021-2031, $ mn
Figure 18. Global Small Molecule CDMO Market by FDF: Semi-solid or Liquid Drugs, 2021-2031, $ mn
Figure 19. Global Small Molecule CDMO Market by FDF: Other FDFs, 2021-2031, $ mn
Figure 20. Breakdown of Global Small Molecule CDMO Market by Service Type, 2021-2031, % of Sales Revenue
Figure 21. Global Addressable Market Cap in 2022-2031 by Service Type, Value ($ mn) and Share (%)
Figure 22. Global Small Molecule CDMO Market by Service Type: Preclinical Use, 2021-2031, $ mn
Figure 23. Global Small Molecule CDMO Market by Service Type: Clinical Use, 2021-2031, $ mn
Figure 24. Global Small Molecule CDMO Market by Clinical Use: Phase I, 2021-2031, $ mn
Figure 25. Global Small Molecule CDMO Market by Clinical Use: Phase II, 2021-2031, $ mn
Figure 26. Global Small Molecule CDMO Market by Clinical Use: Phase III, 2021-2031, $ mn
Figure 27. Global Small Molecule CDMO Market by Clinical Use: Phase IV, 2021-2031, $ mn
Figure 28. Global Small Molecule CDMO Market by Service Type: Commercial Use, 2021-2031, $ mn
Figure 29. Breakdown of Global Small Molecule CDMO Market by Customer Type, 2021-2031, % of Sales Revenue
Figure 30. Global Addressable Market Cap in 2022-2031 by Customer Type, Value ($ mn) and Share (%)
Figure 31. Global Small Molecule CDMO Market by Customer Type: Pharmaceutical Firms, 2021-2031, $ mn
Figure 32. Global Small Molecule CDMO Market by Customer Type: Biotechnology Firms, 2021-2031, $ mn
Figure 33. Breakdown of Global Small Molecule CDMO Market by Therapeutic Area, 2021-2031, % of Revenue
Figure 34. Global Addressable Market Cap in 2022-2031 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 35. Global Small Molecule CDMO Market by Therapeutic Area: Infectious Diseases, 2021-2031, $ mn
Figure 36. Global Small Molecule CDMO Market by Therapeutic Area: Oncology, 2021-2031, $ mn
Figure 37. Global Small Molecule CDMO Market by Therapeutic Area: Ophthalmology, 2021-2031, $ mn
Figure 38. Global Small Molecule CDMO Market by Therapeutic Area: Cardiovascular Disorders, 2021-2031, $ mn
Figure 39. Global Small Molecule CDMO Market by Therapeutic Area: Central Nervous System, 2021-2031, $ mn
Figure 40. Global Small Molecule CDMO Market by Therapeutic Area: Respiratory Disorders, 2021-2031, $ mn
Figure 41. Global Small Molecule CDMO Market by Therapeutic Area: Metabolic Diseases, 2021-2031, $ mn
Figure 42. Global Small Molecule CDMO Market by Therapeutic Area: Other Therapeutic Areas, 2021-2031, $ mn
Figure 43. Global Market Snapshot by Region
Figure 44. Geographic Spread of Worldwide Small Molecule CDMO Market, 2021-2031, % of Sales Revenue
Figure 45. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)
Figure 46. North American Small Molecule CDMO Market, 2021-2031, $ mn
Figure 47. Breakdown of North America Small Molecule CDMO Market by Country, 2021 and 2031, % of Revenue
Figure 48. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 49. U.S. Small Molecule CDMO Market, 2021-2031, $ mn
Figure 50. Canada Small Molecule CDMO Market, 2021-2031, $ mn
Figure 51. Small Molecule CDMO Market in Mexico, 2021-2031, $ mn
Figure 52. European Small Molecule CDMO Market, 2021-2031, $ mn
Figure 53. Breakdown of European Small Molecule CDMO Market by Country, 2021 and 2031, % of Revenue
Figure 54. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 55. Small Molecule CDMO Market in Germany, 2021-2031, $ mn
Figure 56. Small Molecule CDMO Market in U.K., 2021-2031, $ mn
Figure 57. Small Molecule CDMO Market in France, 2021-2031, $ mn
Figure 58. Small Molecule CDMO Market in Spain, 2021-2031, $ mn
Figure 59. Small Molecule CDMO Market in Italy, 2021-2031, $ mn
Figure 60. Small Molecule CDMO Market in Netherlands, 2021-2031, $ mn
Figure 61. Small Molecule CDMO Market in Rest of Europe, 2021-2031, $ mn
Figure 62. Asia-Pacific Small Molecule CDMO Market, 2021-2031, $ mn
Figure 63. Breakdown of APAC Small Molecule CDMO Market by Country, 2021 and 2031, % of Revenue
Figure 64. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 65. Small Molecule CDMO Market in Japan, 2021-2031, $ mn
Figure 66. Small Molecule CDMO Market in China, 2021-2031, $ mn
Figure 67. Small Molecule CDMO Market in Australia, 2021-2031, $ mn
Figure 68. Small Molecule CDMO Market in India, 2021-2031, $ mn
Figure 69. Small Molecule CDMO Market in South Korea, 2021-2031, $ mn
Figure 70. Small Molecule CDMO Market in Rest of APAC, 2021-2031, $ mn
Figure 71. South America Small Molecule CDMO Market, 2021-2031, $ mn
Figure 72. Breakdown of South America Small Molecule CDMO Market by Country, 2021 and 2031, % of Revenue
Figure 73. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 74. Small Molecule CDMO Market in Argentina, 2021-2031, $ mn
Figure 75. Small Molecule CDMO Market in Brazil, 2021-2031, $ mn
Figure 76. Small Molecule CDMO Market in Chile, 2021-2031, $ mn
Figure 77. Small Molecule CDMO Market in Rest of South America, 2021-2031, $ mn
Figure 78. Small Molecule CDMO Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 79. Breakdown of MEA Small Molecule CDMO Market by Country, 2021 and 2031, % of Revenue
Figure 80. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 81. Small Molecule CDMO Market in UAE, 2021-2031, $ mn
Figure 82. Small Molecule CDMO Market in Saudi Arabia, 2021-2031, $ mn
Figure 83. Small Molecule CDMO Market in South Africa, 2021-2031, $ mn
Figure 84. Growth Stage of Global Small Molecule CDMO Industry over the Forecast Period